Highlight A

Highlight A aus der Pharma und Biotechnologie: Ullaorting erciliq uipiscipit, consequat in ullaor sim dolore modole.
  • Emanating innovation
    bright – exciting – resounding
    index.php?id=402 fileadmin/templates/images/leuchtkraft.jpg fileadmin/templates/images/leuchtkraftLarge.jpg
  • The restoration of sight after blindness is an age-old dream that can come true by means of intelligent implants.
    index.php?id=69 fileadmin/templates/images/highlight0.jpg fileadmin/templates/images/highlight0Large.jpg
    Retina Implantat

    Eye chip implant

    Eye chip implant for the blind
    420 250


    Image sensor chip replace degenerated photoreceptors
    480 410
    Biostable materials

    Biostable materials

    Long-term stable encapsulation of micro-implants with biostable materials.
    120 400
  • Speedier test results, more details for test parameters
    and cost-effectiveness are of key importance in the
    development of drugs and future diagnostic procedures.more
    index.php?id=71 fileadmin/templates/images/highlight1.jpg fileadmin/templates/images/highlight1Large.jpg
    Personalized medicine

    Personalized medicine

    Effective treatment with individual drugs
    420 220
    Protein biochips

    Protein biochips

    Sensitive and selective detection of biomarkers
    120 440


    Very small quantities for the diagnosis .
    480 380
  • Surface finishes and coatings
    for applications in surgery and implantology.
    index.php?id=168 fileadmin/templates/images/highlight2.jpg fileadmin/templates/images/highlight2Large.jpg


    Assistance in the development and approval of new instruments and devices.
    420 220


    Tailor-made surfaces and coating systems
    120 440
    Manufacturing process

    Maufacturing process

    Innovative methods for coatings and adhesive systems
    480 380


The Natural and Medical Sciences Institute (NMI) at the University of Tübingen undertakes applied research and development at the interface of life sciences and material sciences.


June 2017 - Dr. Paolo Cesare, Head of Neuro Microphysiological Systems Group at NMI, participates to a newly launched IMI project: Modelling neuron-glia networks into a drug discovery platform for efficacious pain treatments (NGN-PET) more ...

10th - 14th July 2017 - Desire to have children and genome-editing: Ethical, legal and social aspects of genome-editing in in-vitro fertilisation more ...

22.06.2017 - NMI TT Pharmaservices and Charité awarded grant for development of multiplex protein profiling for individualization of tumor therapy more ...

24.5.2017 - High-Tech Gründerfonds (HTGF) invests in Reutlingen-based SIGNATOPE GmbH more ...

12-16 June 2017 - 16th Annual World Preclinical Congress more ...

15-16 Mai 2017 - 2nd Annual Advances in Immuno-Oncology Congress more ...

NMI Technology TransferTo access the website of
our service enterprise, the
NMI Technologie Transfer GmbH
NMI Technology TransferThe NMI is a member of the Baden-Wuerttemberg Innovation Alliance more

Events and Workshops

4.-6.4.2017 - MedTec Europe 2017